| 영문 | food poisoning | 한글 | 식중독 |
|---|---|---|---|
| 설명 | 유해물질에 오염된 음식물을 먹음으로써 일어나는 일군의 급성질환이며, 주로 발열-구역질-구토-설사-복통 등의 증세가 나타난다. 입을 통한 전염병이나 기생충병 등은 여기에 포함되지 않는다. 식중독을 원인물질에 따라 분류하면 세균성 식중독, 화학성 식중독, 자연독 식중독, 미생물 독성대사물질에 의한 식중독으로 구분할 수 있다. 각 부류에 속하는 독성물질은 그 종류가 매우 많으며, 독성물질은 당장 건강을 해칠만한 양이 아니라 하더라도 많은 식품 중에 널리 분포되어 있어서 만성중독-발암성-돌연변이 유발성-기형유발성-알레르기성 반응을 일으키는 원인이 될 수도 있다. 식중독의 대부분은 세균에 의하여 생기는 세균성 식중독으로서, 여기에는 살모넬라-장비브리오-웰치균-병원대장균에 의한 감염형 식중독과 포도알균, 보톨리누스균이 생성한 독소에 의한 독소형 식중독이 있다. 감염형 식중독은 살아 있는 유해세균을 다량으로 먹음으로써 일어나는 것이므로 식품을 가열해서 먹으면 세균은 사멸해 버리기 때문에 중독되는 일이 없다. 그러나 독소형 식중독은 세균은 죽어도 독소는 그대로 남아 있으므로 음식물을 가열해도 남은 독소가 중독을 일으키는 경우이다. 화학성 식중독은 화학물질에 의한 것으로서 근래에 들어와 화학공업의 발달로 화학적 합성품의 대량생산이 가능해지고 이들이 식품공업이나 농업분야에 다량으로 사용되면서 심각한 문제로 등장하였다. 특히 식품가공과정 중에 사용한 불법식품첨가물, 잔류농약-산업폐수에 의한 식품의 중금속오염, 또는 식품과 관련이 있는 각종 용기-기구-포장 등에서 용출되는 독성물질이 문제가 된다. |
||
| 영문 | food | 한글 | 식품, 음식 |
|---|---|---|---|
| 설명 | 1. 몸안에 들어가서 영양분으로 되거나 몸조직을 형성하거나 에너지를 공급하는 물질. 2. 식품. 사람이 일상적으로 섭취하는 음식물을 통틀어 이르는 말. 3. 음식. 사람이 먹을 수 있도록 만든, 밥이나 국 따위의 물건. |
||
| 영문 | staphylococcal food poisoning | 한글 | 포도알균 식중독 |
|---|---|---|---|
| 설명 | 크림이 들어 있는 과자, 커스타드(custards), 치즈와 같은 식품이나, 육류에 황색 포도알균이 생성하는 창자관독이 함유된 것을 섭취하여 일어나는 식중독으로서 갑작스러운 발병, 두통, 침분비, 구역, 구토, 설사, 복부산통 및 땀남을 특징으로 하며, 발작 후 5~6시간 지속한다. |
||
| FD&C | Food, Drug and Cosmetic Act; food, drugs, and cosmetics |
|---|---|
| DASD | Direct Access Storage Device = RAM |
| SPD | Storage Pool Disease |
| CESD | cholesterol ester storage disease |
| CSC | blow on blow (administration of small amounts of drugs at short intervals) [Fr. coup sur coup]; coll... |
| CESD | Cholesterol ester storage disease |
|---|---|
| GSD | Glycogen Storage Disease |
| GSDII | Glycogen Storage Disease type II |
| GSD 1a | Glycogen storage disease type 1a |
| GSD I | Glycogen storage diseases type I |
| brancher glycogen storage disease | Type of glycogen storage disease, due to deficiency of amylo-1,4-1,6-transglucosidase (brancher enzyme). Synonym: brancher deficiency glycogenosis, debrancher deficiency. (05 Mar 2000) |
|---|---|
| glycogen storage disease | <hepatology> A group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalised storage of glycogen occurs, sometimes with prominent cardiac involvement. Synonym: glycogenosis (12 Sep 2002) |
| glycogen storage disease type I | <disease> An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycaemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood. Inheritance: autosomal recessive. (12 Dec 1998) |
| glycogen storage disease type II | <disease> Glycogenosis due to alpha-1,4-glucosidase (acid maltase) deficiency. It affects muscle, heart, and other organs. (12 Dec 1998) |
| glycogen storage disease type III | <disease> An autosomal recessive metabolic disorder due to deficient expression of amylo-1,6-glucosidase (one part of the glycogen debranching enzyme system). The clinical course of the disease is similar to that of glycogen storage disease type I, but milder. Massive hepatomegaly, which is present in young children, diminishes and occasionally disappears with age. Levels of glycogen with short outer branches are elevated in muscle, liver, and erythrocytes. Six subgroups have been identified, with subgroups type IIIa and type IIIb being the most prevalent. Inheritance: autosomal recessive (12 Dec 1998) |
| glycogen storage disease type IV | <disease> An autosomal recessive metabolic disorder due to a deficiency in expression of branching enzyme (alpha-1,4-glucan-6-alpha-glucosyltransferase), resulting in an accumulation of abnormal glycogen with long outer branches. Clinical features are muscle hypotonia and cirrhosis. Death from liver disease usually occurs before age 2. Inheritance: autosomal recessive (12 Dec 1998) |
| glycogen storage disease type V | <disease> Glycogenosis due to muscle phosphorylase deficiency. Characterised by painful cramps following sustained exercise. Inheritance: autosomal recessive (12 Dec 1998) |
| glycogen storage disease type VI | <disease> A hepatic glycogen storage disease in which there is an apparent deficiency of hepatic phosphorylase activity. However, studies have not been able to distinguish between phosphorylase deficiency and phosphorylase kinase deficiency in patients with hepatic glycogenosis. (12 Dec 1998) |
| glycogen storage disease type VII | <disease> An autosomal recessive muscle glycogen storage disease in which there is deficient expression of muscle phosphofructokinase activity, resulting in increased concentrations of glucose-6-phosphate and fructose-6-phosphate and low concentrations of fructose-1,6-diphosphate in muscle tissue. Glycogen storage in muscle is increased, perhaps due to activation of glycogen synthase by accumulated glucose-6-phosphate. It has been proposed that shunting of glucose-6-phosphate and fructose-6-phosphate into the pentose phosphate pathway may result in increased synthesis of purines and pyrimidines, causing hyperuricaemia and gout. Erythrocytes from patients may show decreased phosphofructokinase activity and 2,3-diphosphoglycerate deficiency. Exercise intolerance is present and severe congenital muscular dystrophy has been reported. Inheritance: autosomal recessive (12 Dec 1998) |
| glycogen storage disease type VIII | <disease> An x-linked recessive hepatic glycogen storage disease resulting from lack of expression of phosphorylase-b-kinase activity. Symptoms are relatively mild; hepatomegaly, increased liver glycogen, and decreased leukocyte phosphorylase are present. Liver shrinkage occurs in response to glucagon. Inheritance: X-linked recessive (12 Dec 1998) |
| cholesterol ester storage disease | A rare benign adult form of inherited lysosomal lipid storage disease that is due to deficiency of acid lipase. It results in an accumulation of neutral lipids, particularly cholesterol esters, within cells (particularly leukocytes, fibroblasts, and liver cells). It is an allelic variant of wolman disease. (12 Dec 1998) |
| phytanic acid storage disease | A genetic disorder of the fatty acid phytanic acid which accumulates and causes a number of progressive problems including polyneuritis (inflammation of numerous nerves), diminishing vision (due to retinitis pigmentosa), and wobbliness (ataxia) caused by damage to the cerebellar portion of the brain (cerebellar ataxia). (12 Dec 1998) |
| computer storage devices | Devices capable of receiving data, retaining data for an indefinite or finite period of time, and supplying data upon demand. (12 Dec 1998) |
| platelet storage pool deficiency | A group of disorders characterised by a decrease or lack of platelet dense bodies in which the releasable pool of adenine nucleotides and 5ht are normally stored. (12 Dec 1998) |
| cystine storage disease | Lysosomal storage disorders of unknown molecular defect, characterised by widespread deposition of cystine crystals in reticuloendothelial cells. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|